Darwin Global Management, Ltd. Keros Therapeutics, Inc. Transaction History
Darwin Global Management, Ltd.
- $1.23 Billion
- Q3 2024
A detailed history of Darwin Global Management, Ltd. transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 1,523,732 shares of KROS stock, worth $25.9 Million. This represents 7.2% of its overall portfolio holdings.
Number of Shares
1,523,732
Previous 1,525,902
0.14%
Holding current value
$25.9 Million
Previous $69.7 Million
26.89%
% of portfolio
7.2%
Previous 8.43%
Shares
11 transactions
Others Institutions Holding KROS
# of Institutions
174Shares Held
30.3MCall Options Held
76.8KPut Options Held
9K-
Black Rock Inc. New York, NY2.51MShares$42.8 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.9MShares$32.3 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$31.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.51MShares$25.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.11MShares$19 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $439M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...